 FARMINGDALE, N.Y., Feb. 04, 2021 GLOBE NEWSWIRE -- Misonix, Inc. Nasdaq: MSON Misonix or the Company, a provider of minimally invasive therapeutic ultrasonic medical devices and regenerative products that enhance clinical outcomes, today reported financial results for the fiscal 2021 second quarter ended December 31, 2020 as summarized below: 